The study, led by researchers at King’s College London and the Francis Crick Institute, found that 95 per cent of cancer patients given two Pfizer vaccine doses three weeks apart showed a strong immune response. The response was much weaker after a single dose, however, with just 8% of blood cancer patients testing positive for antibodies five […] View
